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Abstract: Immune system activation and inflammation accompanies immune dysfunction in trauma and sepsis patients. Immunodefi-
ciency may develop in such patients as one consequence of an activated chronic pro-inflammatory response. According to recent data, 
degradation of L-tryptophan (TRP) via the kynurenine (KYN) pathway by the cytokine-inducible enzyme indoleamine 2,3-dioxygenase 
(IDO) could represent an important contributor to the deficient responsiveness of immunocompetent cells. Compared to healthy con-
trols, patients post trauma or with sepsis had increasing KYN concentrations and KYN to TRP ratios (KYN/TRP) whereas TRP con-
centrations decreased. Likewise, concentrations of cytokines tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) and of immune 
activation marker neopterin increased in patients (all p  0.001). Furthermore in patients KYN/TRP, KYN and neopterin concentrations 
were further increasing (all p  0.001), whereas the changes of TRP, TNF-α and IL-6 concentrations were not significant. Compared 
to the survivors, the non-survivors had a higher concentration of KYN, neopterin, TNF-α and IL-6 as well as a higher KYN/TRP ratio. 
KYN/TRP correlated with neopterin (p  0.001) and also with TNF-α (p  0.01) and IL-6 concentrations (p  0.05) and inversely with 
the in vitro response of stimulated monocytes. We conclude that increased TRP degradation in patients post trauma is closely associated 
with immune activation. Cytokines released during the pro-inflammatory response may induce the activity of IDO and thus accelerate 
TRP degradation. Thus, increased IDO activity most likely represents a result of host response to pro-inflammation in patients. Data 
support a possible role of inflammation-induced IDO in the diminished immunoresponsiveness in patients.
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Introduction
Trauma is the main cause of death for people below 
the  age  of  40  years.1  Multiple  trauma—which  is 
synonymous  to  severe  trauma,  major  trauma  or 
polytrauma—is defined as physical insults or inju-
ries occurring simultaneously in at least two differ-
ent body regions. The sum of those injuries represents 
a  life  threatening  situation.  In  literature  the  Injury 
Severity Score (ISS) of more than 16 points is widely 
used to define a multiple trauma.2 After a huge physi-
cal impact like a trauma, destroyed tissue needs to 
be cleared and this leads to an activation of several 
immune system compartments and cytokine cascades 
followed by a systemic inflammatory response.3 This 
reaction, often accompanied by a counter-regulation, 
diminishes immune function and can lead to immune 
paralysis (Fig. 1).4 The extent of this immune dys-
function is crucial for the outcome of the patient.
Monocytes play a key role in the innate immune 
system.  After  activation  for  example  by  lipopoly-
saccharid (LPS) via toll-like receptors (TLR) or by 
destroyed tissue, monocytes produce pro-inflammatory 
cytokines such as interleukin-(IL)-1, IL-6, IL-8 and 
IL-12, interferon-γ (IFN-γ), transforming growth factor-β 
(TGF) and tumor necrosis factor-α (TNF-α) as well 
as prostaglandins, complement and neopterin (Fig. 3). 
After trauma, the TNF-α concentration in patients’ is 
reduced.5,6  Furthermore,  diminished  TNF-α  produc-
tion in blood following ex vivo LPS stimulation is a 
very important predictive marker in traumatic patients 
and more sensitive than other markers in predicting 
unfavorable outcome.7 In a similar way, IFN-γ-produc-
tion in stimulated peripheral blood mononuclear cells 
of patients as compared to controls and this deficient 
IFN-γ-response is considered to be crucially involved 
in poor survival expectations.4 But notably, IFN-γ defi-
ciency is often observed only upon in vitro-stimulation 
of cells and is paralleled by signs of activated immu-
nity in vivo.8
IFN-γ, next to other effects, strongly induces the 
enzyme  indoleamine  2,3-dioxygenase  (IDO).  IDO 
catalyzes the initial and rate-limiting step of trypto-
phan (TRP) to kynurenine (KYN).9 This TRP degra-
dation by IDO inhibits the growth of viruses, bacteria 
and parasites but also tumor cells10,11 because TRP is 
the least available and therefore most important essen-
tial amino acid for their growth. In trauma patients, 
a higher IDO activity not only leads to a decline in 
lymphocyte  counts  but  is  also  associated  with  an 
unfavorable outcome.12,13
In patients with trauma and sepsis increased lev-
els of IL-6, TNF-α and neopterin are also well docu-
mented to predict outcome.13–17 TNF-α enhances the 
IFN-γ-induced IDO activity and at the same time trig-
gers neopterin production in a synergistic fashion.18 
Accordingly, in several groups of patients suffering 
from different diseases like infections, auto-immune 
syndromes, cancer and trauma increased IDO activity 
is paralleled by higher levels of neopterin.12,13,19–22
In  a  recent  study  we  analyzed  plasma  samples 
from trauma patients and determined the amounts of 
TRP and KYN and calculated the KYN to TRP ratio 
(KYN/TRP) as an index of IDO activity. The objec-
tives of this study were to compared those values to 
the plasma concentrations of IL-6, TNF-α, neopterin 
as well as the ex vivo production of TNF-α after LPS 
stimulation and finally to correlate those results with 
the outcome.13,23
study
Eighteen patients were included in this study: 14 males, 
4 females; aged mean ± S.D.: 45 ± 19 years, range: 
20–77 years, 15 trauma patients and 3 surgical patients 
who  developed  sepsis;  Apache  score:  18.9  ±  6.75 
range: 8–34; ISS: 39 ± 13.1, range: 18–57. Patients 
were either admitted to the Intensive Care Unit (ICU) 
of the Lorenz Boehler Trauma Center or the ICU of the 
Medical University of Vienna. Samples were collected 
every third day during the first 14 days of follow up. 
For statistical analyses, samples were divided into five 
groups: one sample collected between days 1–2 of each 
patient was referred to as group I, day 3–5 = group II, 
day 6–8 = group III, days 9–12 = group IV, and days 
13–14 = group V. In total, every patient contributed 
3–5 plasma samples to the total number of 84 sera 
analyzed.23
Samples from 49 healthy donors (21 women and 
28 men; age, 35 ± 13.5 years) served as a reference 
group  for  kynurenin,  tryptophan  and  neopterin.20 
A different group of healthy volunteers served as a ref-
erence group for TNF-α, IL-6 and ex vivo LPS stim-
ulated TNF-α as published recently.7 The study was 
performed according to the Helsinki declaration. The 
protocol was approved by the local ethics committee, Accelerated tryptophan degradation predicts poor survival
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and written consent was granted by the next of kin. 
The observed values of all study parameters had no 
influence whatsoever on the course of the therapy.
Concentrations of TRP and KYN were determined 
by high performance liquid chromatography (HPLC) 
as described before using 3-nitro-L-tyrosine as external 
standard.24,25 Tryptophan was detected by its natural flu-
orescence at an excitation wavelength of 285 nm and an 
emission of 365 nm. UV absorption of both compounds, 
KYN and L-nitrotyrosine, was monitored at a wavelength 
of 360 nm. KYN/TRP was calculated and expressed as 
µmol KYN per mmol TRP. Neopterin was measured by 
ELISA (BRAHMS, Hennigsdorf, Germany) according 
to the manufacturer’s instructions with a detection limit 
of 2 nM. Serum levels of TNF-α and IL-6 were mea-
sured  with  Immulite  semi-automated  chemolumines-
cent immunoassay analyzer (DPC, Los Angeles, CA; 
detection limits were 1.7 pg/mL for TNF-α and 2 pg/mL 
for IL-6). Ex vivo stimulation of monocytes with LPS 
was performed with a commercially available test kit 
(Ex vivo Stimulation Kit, Milenia Biotec GmbH, Bad 
Nauheim, Germany),7 and measurement of TNF-α on 
the Immulite semi-automated chemiluminescent immu-
noassay analyzer (DPC, Los Angeles, CA).
Statistical analysis was performed with the statis-
tical software package SPSS for Windows (version 
17.0; SPSS Inc., Chicago, Ill) applying non-parametric 
tests such as Kruskal Wallis-test and Mann Whitney 
U-test and Spearman’s rank correlation coefficients 
(rs) were calculated, p-values  0.05 were considered 
statistically significant.
Results
Concentrations of TRP were decreased in all trauma 
patients at all time compared to the normal range in 
healthy controls, whereas KYN/TRP and concentra-
tions of KYN were increased in patients (Table 1). 
Also plasma concentrations of neopterin, TNF-α and 
IL-6 were increased in patients compared to healthy 
controls, whereas TNF-α production after ex vivo LPS 
stimulation was decreased (Table 1). However, TNF-α 
was detectable in less than half of the specimens.23
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Figure 1. Schematic drawing of immunoregulatory events that are critically involved in the pathogenesis of a systemic inflammatory response syndrome 
(SIRS) and sepsis with increased production of pro-inflammatory cytokines like interleukin (IL)-1, -6, -8 an tumor necrosis factor-α (TnF-α). sIRs and 
sepsis are often followed by severe immunosuppression due to a compensatory anti-inflammatory reaction syndrome (CARS) which involves overproduc-
tion of anti-inflammatory cytokines IL-10, -4, -13, -10 and reduced functional immunoresponsiveness as is indicated by reduced human leukocyte antigen 
(hLA)-DR expression and diminished TnF-α release upon exposure to lipopolysaccharide (Lps).ploder et al
64  International Journal of Tryptophan Research 2010:3
Patients who died during follow-up did not differ 
from survivors regarding age, gender, main diagno-
ses, length of stay in ICU, their Apache II scores or 
trauma  scores  ISS.  However,  those  who  died  pre-
sented with significantly higher KYN/TRP at several 
time points (Fig. 2).
Discussion
In patients with sepsis after trauma or surgery there 
occured significant alterations of TRP metabolism as 
compared to healthy controls: TRP concentrations were 
decreased  whereas  KYN  concentrations  and  KYN/
TRP were elevated in patients. Moreover, a higher rate 
of KYN accumulation and a higher KYN/TRP and 
were predictive for a bad outcome. Also neopterin, 
TNF-α and IL-6 concentrations were higher in non-
survivors compared to survivors at several time points 
during  follow-up.  Ex  vivo  TNF-α  production  after 
LPS-stimulation was significantly decreased in non-
survivors compared to survivors. In the whole data 
set, there existed a positive correlation between KYN 
concentrations and neopterin as well as KYN/TRP and 
neopterin. KYN/TRP correlated also with TNF-α (all 
p  0.001). TNF-α correlated with neopterin and IL-6 
(both p  0.001; data not shown). These results agree 
well with earlier observations.13,23
Low TRP concentrations are unlikely to be related 
to a reduced dietary intake of this essential amino acid, 
because patients receiving standardized enteral or par-
enteral nutrition at the ICU. Increased IDO activity may 
indeed account for lowered TRP concentrations, and 
seems likely to be induced by pro-inflammatory stimuli, 
of which IFN-γ together with TNF-α are considered to 
be the strongest inducer of IDO in macrophages and 
dendritic cells. Immunocompetent cells respond against 
non-self  structures  and  produce  cytokines  including 
IFN-γ and TNF-α which are aimed at halting growth of 
pathogens. Thus, an overwhelming Th1-type immune 
activation may be the cause for the enhanced IDO activity 
(Fig. 3). In our data several strong correlations were 
Table 1. concentrations of Interleukin-6, constitutive tumor necrosis factor-α (TnF-α), TnF-α production after ex vivo 
lipopolysaccharide (Lps) stimulation, tryptophan, kynurenine and neopterin and of kynurenine to tryptophan ratio (KYn/
TRp) (mean ± s.D., range in brackets; data from all patients from all groups) in patients post-trauma and/or with sepsis 
(18 patients, 84 measurements) and laboratory reference values of healthy controls (Ref. 13 and 23). 
patients controls
Interleukin-6 345 ± 579 (6.7–3741)*** 5.0 ± 0.0
constitutive TFn-α 13.4 ± 62.9 (4.0–650) 5.0 ± 0.0
TnF-α after Lps 571 ± 457 (20.4–2985)*** 2070 ± 679
Tryptophan (µM) 37.0 ± 12.5 (11.1–73.8)** 73.0 ± 14.9
Kynurenine (µM) 3.99 ± 2.93 (0.70–14.6)** 1.92 ± 0.58
Kyn/trp (µM/mM) 123 ± 120 (28.7–810)** 26.9 ± 8.10
neopterin (nM) 30.3 ± 36.4 (4.0–168)** 5.3 ± 2.7
**p  0.01, ***p  0.001, patients versus controls.
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Figure 2. Serum kynurenine to tryptophan ratio in 18 patients with sepsis 
after trauma or surgery. Data are presented as box plots with median 
values and interquartile ranges. The black boxes show non-survivors and 
the white boxes show survivors. circles indicate extreme values, asterisks 
indicate significance differences between survivors and non-survivors.
**p  0.01, ***p  0.001.Accelerated tryptophan degradation predicts poor survival
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observed between concentrations of pro-inflammatory 
cytokines and of neopterin and the increase of KYN/
TRP which supports our conclusion.
Activation of IDO is one out of several important 
antimicrobial mechanisms triggered by IFN-γ. How-
ever activated IDO does not only affect microbes, it 
potentially may also counteract growth and devel-
opment  of  T-cells.26  TNF-α  was  shown  earlier  to 
enhance TRP degradation and neopterin production 
in  monocyte-derived  macrophages  in  a  synergistic 
way to IFN-γ.18 In our patients we found a significant 
correlation between KYN/TRP and TNF-α concen-
trations, and an even stronger correlation was found 
between KYN/TRP and neopterin. The accelerated 
TRP  degradation  and  the  increased  production  of 
neopterin and pro-inflammatory cytokines were found 
to be associated with a reduced TNF-α production of 
monocytes upon ex vivo stimulation with LPS. Prob-
ably the permanent stimulation and cytokine produc-
tion during disease progression renders these cells 
refractory to further stimulation.8 In fact, activation 
of antiproliferative biochemical pathways as part of 
the effector functions of a Th1-type immune response 
(Fig. 3) would well fit to the common finding of an 
immunosuppressed  state  in  patients  suffering  from 
chronic inflammatory conditions.
TNF-α was below detection limit in more than 
half of the patients, and circulating IFN-γ concentra-
tions in serum/plasma of patients are usually even 
less detectable than TNF-α. That is why we refrained 
from analyzing IFN-γ concentrations in our patients. 
These cytokines rapidly stick to their specific recep-
tors on target cells or to their shed soluble forms, so 
their low concentrations in serum/plasma are limit-
ing the diagnostic application. TNF-α and IL-6 con-
centrations were higher in non-survivors compared 
to  survivors  already  at  baseline  confirming  earlier 
results of others.14,15 TNF-α concentrations predicted 
mortality throughout the later post-traumatic course, 
whereas  IL-6  concentrations  were  less  predictive. 
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Figuer 3. Within the systemic inflammatory response syndrome (SIRS) and sepsis pro-inflammatory cytokine interferon-γ (IFn-γ) is released by mainly 
T-cells and natural killer (NK) cells. Among other pro-inflammatory stimuli, IFN-γ strongly stimulates production of additional cytokines like interleukin-1 
(IL-1) and tumor necrosis factor-α (TnF-α), neopterin and reactive oxygen species (ROs) in monocyte-derived macrophages (MΦ) and dendritic cells 
(Dc), aimed at suppressing growth of infectious agents (gray arrows). In parallel antiproliferative enzymes like indoleamine 2,3-dioxygenase (IDO) are 
expressed. In turn, anti-proliferative action also affects immunoresponsiveness and thus a suppressed immune system status is reached.
Abbreviations: FOXp3, forkhead box p3; cTLA4, cytotoxic T-Lymphocyte Antigen 4.ploder et al
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Still,  IL-6  concentrations  correlated  strongly  with 
TRP degradation. In addition, a rather strong rela-
tionship existed between TNF-α and neopterin con-
centrations. Overall, the changes of KYN/TRP and of 
KYN, neopterin, TNF-α and IL-6 concentrations post 
trauma showed similar courses in all non-survivors, 
and they seemed to reflect the pro-inflammatory cas-
cades quite well, which were related to overwhelming 
production TNF-α and probably also of IFN-γ. Thus, 
pro-inflammatory cytokines seemed to trigger those 
critical events probably leading to death, and TRP 
degradation via IDO could indeed represent one of 
the most important players. This is a surprising result, 
because at first glance one might expect that a higher 
degree  of  immune  response  should  be  in  favor  of 
increased patients’ survival, when, e.g. clearance of 
pathogens might be enhanced by the antimicrobial 
mechanisms, but obviously the opposite is the case.
A kind of equilibrium might develop between the 
activation  degree  of  immunocompetent  cells,  their 
suppressive effect on microbes and also the effect on 
themselves. In some patients the bactericidal effect 
of IDO will be able to stop the infectious process, 
in other patients immunocompetent cells are suffer-
ing more from IDO activity than microbes. Further-
more, depletion of T-cells and immunosuppression is 
a consequence of the host’s immune response against 
invading pathogens. In fact we also observed a nega-
tive relationship between the capacity of monocytes 
to respond to LPS stimulation and KYN/TRP. This 
data is supporting the concept that immunocompetent 
cells of patients after trauma and sepsis are somewhat 
exhausted from their chronic activation in patients 
rather than being per se refractory. But certainly this 
study is too preliminary to give a final answer to this 
question.
From in vitro studies it was concluded that not only 
the decline of TRP concentrations but also the increase 
formation of toxic TRP catabolites could be involved 
in the development of T-cell unresponsiveness.26,27 
Interestingly in our study, only the increase of KYN 
concentrations but not the decline of TRP was sig-
nificantly associated with the outcome of patients. 
Supplementation  of  TRP  via  standard  enteral  or 
parenteral  nutrition  was  initiated  early  in  all  our 
patients. This may have counteracted to some degree 
the loss of TRP despite further accelerating degrada-
tion of the amino acid and further increase of KYN 
concentrations. Still, data may favor a role of TRP 
catabolites,26 rather than TRP lowering in the immune 
deviations which might be of relevance for the fatal 
outcome of some of our patients. KYN and its down-
stream metabolites are able to modulate redox chem-
istry: Recently, KYN was found to influence the lipid 
biosynthesis in rat liver cells in a rather pro-oxidative 
way. In fact, the influence was similar to macrophage 
product  neopterin  which  shifts  biosynthesis  away 
from unsaturated towards saturated fatty acids.29 The 
property of TRP catabolites to shift redox equilibria 
has also been demonstrated when the chemolumines-
cence output from H2O2- and hypochlorite-containing 
aqueous solutions was compared between samples 
with and without kynurenine and other tryptophan 
catabolites.30 Such findings could relate also to the 
pro-apoptotic nature of these chemicals.27
conclusion
Accelerated TRP degradation and higher concentra-
tions of neopterin and TNF-α are prognostic factors for 
shortened survival in patients post trauma, which con-
firms and extends earlier data. Tryptophan degradation 
may represent one important aspect in the development 
of the post traumatic failure of the immune system 
to respond appropriately. More extended studies are 
needed to examine the impact of TRP degradation and 
its relationship with cellular immune activation and 
the potential prognostic value of TRP metabolism in 
patients suffering from trauma, which should be help-
ful to define new therapeutic intervention strategies.
Finally, these observations on TRP catabolism in 
patients with trauma and sepsis may just reflect the 
special role of pro-inflammatory cascades which con-
tribute to the fate of such patients and may be regarded 
as one out of many antiproliferative effector functions 
which are initiated in such clinical conditions.
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